BioStem Technologies, Inc. (BSEM)
3.65
+0.11
(+3.11%)
USD |
NASDAQ |
Sep 03, 13:41
BioStem Technologies Research and Development Expense (Annual) : 7.086M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.086M |
| December 31, 2024 | 1.911M |
| December 31, 2023 | 0.342M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.2248M |
| December 31, 2021 | 0.1196M |
| December 31, 2020 | 0.0573M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Filana Therapeutics, Inc. | 26.59M |
| CorMedix, Inc. | 19.33M |
| Eloxx Pharmaceuticals, Inc. | 3.056M |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.0042M |